International Chair on Cardiometabolic Risk

CMR Short Reviews
- The Concept of CMR
  Historical background on global cardiometabolic risk, epidemiological aspects of obesity and type 2 diabetes, ABCs of cardiovascular disease risk factors, intra-abdominal adiposity, metabolic syndrome and contribution to cardiometabolic risk.
- Evaluating CMR
  Research and clinical tools to identify individuals with excess intra-abdominal adiposity and quantify their risk of diabetes and cardiovascular disease (global cardiometabolic risk).
- Managing CMR
  Notions and practical tools to better manage the abdominally obese patient with excess intra-abdominal adiposity and related clustering abnormalities.
Documentation Centre
- Slides, videos and more

News

June 30, 2009 Abdominal Obesity / Body Fat Distribution, Diabetes, News

Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr 2009;89:807-14

Gallagher D, Kelley DE, Yim JE et al.

Differences in body fat distribution between patients with type 2 diabetes (n=56 women and 37 men) and healthy controls (n=64 women and 29 men) were examined in an ancillary study group of the Look AHEAD trial. Areas of total, subcutaneous, intra-abdominal (visceral) and intermuscular adipose tissue were quantified by magnetic resonance imaging. Results of the study indicated that adipose tissue distribution was significantly different in subjects with type 2 diabetes. For instance, patients with type 2 diabetes were characterized by more intra-abdominal and intermuscular adipose tissue and less subcutaneous adipose tissue than healthy controls.

Pubmed article

The content of this website is provided for educational and informational purposes only and is not to be used for medical advice, diagnosis or treatment. Use of this site is subject to the terms and conditions contained in our Legal Notices.